Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain

INTRODUCTION: Current antiretroviral therapies (ARTs) have improved outcomes for people living with HIV. However, the requirement to adhere to lifelong daily oral dosing may be challenging for some people living with HIV, leading to suboptimal adherence and therefore reduced treatment effectiveness....

Descripción completa

Detalles Bibliográficos
Autores principales: Moreno, Santiago, Rivero, Antonio, Ventayol, Pere, Falcó, Vicenç, Torralba, Miguel, Schroeder, Melanie, Neches, Victoria, Vallejo-Aparicio, Laura Amanda, Mackenzie, Isaac, Turner, Matthew, Harrison, Cale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505114/
https://www.ncbi.nlm.nih.gov/pubmed/37452174
http://dx.doi.org/10.1007/s40121-023-00840-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505114/
https://www.ncbi.nlm.nih.gov/pubmed/37452174
http://dx.doi.org/10.1007/s40121-023-00840-y

Ejemplares similares